People

Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
Email: Charles.Cleland@nyulangone.org
Education
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
BIO
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Publications

Recent

Palamar JJ, Abukahok N, Denn MT, Acosta P, Cleland CM, Walton SE, Stang B, Krotulski AJ (2026).
Detection of party drugs on mobile phones in relation to self-reported use and oral fluid detection among NYC nightclub attendees
Journal of Studies on Alcohol and Drugs [Epub 2026 Mar 19]. doi: 10.15288/jsad.26-00031.

Heng S, Ye XC, Strayhorn JC, Cleland CM, Parameswaran L, Gwadz M (2026).
Selecting optimized behavioral interventions from an optimization randomized controlled trial on increasing COVID-19 testing for African American/Black and Latino frontline essential workers not up-to-date on COVID-19 vaccination
Annals of Behavioral Medicine, 60 (1). doi: 10.1093/abm/kaag005.

Shelley D, Armstrong-Hough M, Nguyen T, Guevera Alvarez G, Kapur R, Shuter J, Goldsamt L, Tozan Y, Minh HV, Phan PT, Cleland CM, Nguyen N (2026).
Effectiveness of behavioural tobacco cessation interventions with and without pharmacotherapy among people living with HIV in Viet Nam: A three-arm pragmatic randomised controlled trial
Lancet Global Health, 14 (3), e407-e416. doi: 10.1016/S2214-109X(25)00451-6. PMCID: PMC12952184.

Bunting AM, Griffin B, Rubens A, Lima D, Lam V, Bender M, Fawole A, McNeely J, Cleland CM (2026).
Refining a novel measure of polysubstance use: Applying the cognitive interview method with people who use drugs
Substance Use and Misuse [Epub 2026 Feb 20]. doi: 10.1080/10826084.2026.2632181.

Bunting AM, Cleland CM, Barratt SM, Griffin B, Williams J, Oser CB, Lee JD, McNeely J (2026).
The polysubstance assessment tool: Reliability, acceptability and feasibility of a novel measure of polysubstance use
Addiction [Epub 2026 Feb 12]. doi: 10.1111/add.70349.


Notable

Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press